Soleus Capital Master Fund, L.P. - 30 Jun 2025 SCHEDULE 13G/A Report for RIGEL PHARMACEUTICALS, INC. Common Stock, $0.001 par value per share (RIGL)

Filing Manager
Soleus Capital Master Fund, L.P.
Reporting Manager
Soleus Capital Master Fund, L.P.
Security
RIGEL PHARMACEUTICALS, INC. Common Stock, $0.001 par value per share
Symbol
RIGL
Shares outstanding
17,787,703 shares
Disclosed Ownership
658,145 shares
Ownership
3.7%
Form type
SCHEDULE 13G/A
Filing time
05 Aug 2025, 17:00:03 UTC
Date of event
30 Jun 2025
Previous filing
11 Feb 2025
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"Soleus Capital Master Fund, L.P. disclosed 3.7% ownership in RIGEL PHARMACEUTICALS, INC. Common Stock, $0.001 par value per share (RIGL) on 30 Jun 2025."

Quick Takeaways

  • Soleus Capital Master Fund, L.P. filed SCHEDULE 13G/A for RIGEL PHARMACEUTICALS, INC. Common Stock, $0.001 par value per share (RIGL).
  • Disclosed ownership: 3.7%.
  • Date of event: 30 Jun 2025.

What Changed

  • Previous schedule filing date: 11 Feb 2025.
  • Current filing was accepted on 05 Aug 2025, 17:00.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (6)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Soleus Capital Master Fund, L.P. 3.7% 658,145 0 658,145 /s/ Guy Levy Guy Levy/Managing Member
Soleus Capital, LLC 3.7% 658,145 0 658,145 /s/ Guy Levy Guy Levy/Managing Member
Soleus Capital Group, LLC 3.7% 658,145 0 658,145 /s/ Guy Levy Guy Levy/Managing Member
Soleus Capital Management, L.P. 3.7% 658,145 0 658,145 /s/ Guy Levy Guy Levy/Managing Member
Soleus GP, LLC 3.7% 658,145 0 658,145 /s/ Guy Levy Guy Levy/Managing Member
Guy Levy 3.7% 658,145 0 658,145 /s/ Guy Levy Guy Levy

Sponsored